ESC 365 - Targeting left ventricular lead implantation towards the latest electrical activation improves left ventricular ejection fraction in cardiac resynchronization therapy: a randomized controlled trial - Discussion

EHRA Premium Access

Targeting left ventricular lead implantation towards the latest electrical activation improves left ventricular ejection fraction in cardiac resynchronization therapy: a randomized controlled trial - Discussion

Session: Late-breaking trials 2

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor K. Ellenbogen (Richmond, US)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor Kenneth Ellenbogen

Virginia Commonwealth University, Richmond (United States of America)

3 presentations

18 followers

8 more presentations in this session

Speckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients with ischemic CMP- the raise CRT trial

Speaker: Professor M. Glikson (Jerusalem, IL)

Speckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients with ischemic CMP- the raise CRT trial - Discussion

Speaker: Professor F. Leyva (Birmingham, GB)

Targeting left ventricular lead implantation towards the latest electrical activation improves left ventricular ejection fraction in cardiac resynchronization therapy - ElectroCRT

Speaker: Doctor C. Stephansen (Aarhus, DK)

A prospective randomised controlled trial of cardiac resynchronisation therapy guided by invasive LV dP/dt

Speaker: Doctor M. Sohal (London, GB)

A prospective randomised controlled trial of cardiac resynchronisation therapy guided by invasive LV dP/dt - Discussion

Access the full session

Late-breaking trials 2

Speakers: Doctor K. Ellenbogen, Professor M. Glikson, Professor F. Leyva, Doctor C. Stephansen, Doctor M. Sohal

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources